MarketCap
VistaGen Therapeutics VTGN
€ 0.15
-5.19%
Facebook
X
Telegram
VistaGen Therapeutics EV | VTGN
EV Jährlich VistaGen Therapeutics
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.96 M | 20.3 M | -36.8 M | 4.13 M | -46.6 M | -77.4 M | 29.4 M | 24.4 M | 7.87 M | 15.1 M | 18.6 M | 31.4 M | 23.6 M | 28.7 M | 42.8 M | -139 K | -201 K | - | - | - | - | - | - | - | - | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 42.8 M | -77.4 M | 5.25 M |
EV anderer Aktien in der Pharmaeinzelhändler
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Sigilon Therapeutics
SGTX
|
45.9 M | - | - | $ 728 M |  USA |
 |
Rubius Therapeutics
RUBY
|
4.81 M | - | -33.55 % | $ 7.81 M | USA |
 |
Aptinyx
APTX
|
-18.3 M | - | -39.0 % | $ 4.57 M | USA |
 |
TRACON Pharmaceuticals
TCON
|
-2.67 M | - | -1.38 % | $ 46.8 M | USA |
 |
Edesa Biotech
EDSA
|
497 K | $ 2.56 | -7.58 % | $ 14.5 M | USA |
 |
Greenwich LifeSciences
GLSI
|
386 M | $ 17.42 | 8.67 % | $ 236 M | USA |
 |
Mirati Therapeutics
MRTX
|
2.53 B | - | - | $ 3.3 B | USA |
 |
Revance Therapeutics
RVNC
|
972 M | - | - | $ 309 M | USA |
 |
InVivo Therapeutics Holdings Corp.
NVIV
|
-10.1 M | - | -37.48 % | $ 476 K | USA |
 |
Epizyme
EPZM
|
27.9 M | - | - | $ 249 M | USA |
 |
Bellicum Pharmaceuticals
BLCM
|
-9.74 M | - | -9.72 % | $ 5.89 M | USA |
 |
Forward Pharma A/S
FWP
|
513 M | - | -0.75 % | $ 18.7 M |  Danmark |
 |
Orchard Therapeutics plc
ORTX
|
724 M | - | 1.02 % | $ 90.8 M |  Britain |
 |
La Jolla Pharmaceutical Company
LJPC
|
248 M | - | - | $ 154 M | USA |
 |
Oyster Point Pharma
OYST
|
242 M | - | - | $ 300 M | USA |
 |
Nabriva Therapeutics plc
NBRV
|
20.2 M | - | - | $ 4.55 M |  Irlanda |
 |
Intercept Pharmaceuticals
ICPT
|
1.12 B | - | - | $ 643 M | USA |
 |
NGM Biopharmaceuticals
NGM
|
91.5 M | - | - | $ 127 M | USA |
 |
Regulus Therapeutics
RGLS
|
-30.8 M | - | - | $ 155 M | USA |
 |
9 Meters Biopharma
NMTR
|
35.6 M | - | -42.97 % | $ 1.05 M | USA |
 |
Chinook Therapeutics
KDNY
|
1.41 B | - | - | $ 2.6 B | USA |
 |
Lumos Pharma
LUMO
|
2.85 M | - | - | $ 35.3 M | USA |
 |
Syros Pharmaceuticals
SYRS
|
25.9 M | - | -8.44 % | $ 3.4 M | USA |
 |
Gamida Cell Ltd.
GMDA
|
283 M | - | -18.25 % | $ 5.04 M |  Israel |
 |
Citius Pharmaceuticals
CTXR
|
57.7 M | $ 0.45 | 13.31 % | $ 4.98 M | USA |
 |
Aravive
ARAV
|
58.2 M | - | -13.39 % | $ 1.45 M | USA |
 |
Bellerophon Therapeutics
BLPH
|
77.1 M | - | -74.18 % | $ 955 K | USA |
 |
Novo Nordisk A/S
NVO
|
541 B | $ 39.12 | 0.17 % | $ 174 B | Danmark |
 |
Abeona Therapeutics
ABEO
|
234 M | $ 4.33 | -1.7 % | $ 229 M | USA |
 |
AIM ImmunoTech
AIM
|
13.7 M | $ 0.16 | 3.97 % | $ 259 K | USA |
 |
Akebia Therapeutics
AKBA
|
493 M | $ 0.63 | 11.85 % | $ 162 M | USA |
 |
Aldeyra Therapeutics
ALDX
|
284 M | $ 0.64 | -2.15 % | $ 38.4 M | USA |
 |
Alnylam Pharmaceuticals
ALNY
|
43.3 B | $ 228.15 | 1.84 % | $ 29.9 B | USA |
 |
Altimmune
ALT
|
329 M | $ 2.04 | -3.77 % | $ 180 M | USA |
 |
Assembly Biosciences
ASMB
|
301 M | $ 19.65 | -0.96 % | $ 220 M | USA |
 |
Ascendis Pharma A/S
ASND
|
14 B | $ 245.48 | 0.87 % | $ 14.9 B | Danmark |
 |
Beam Therapeutics
BEAM
|
3.15 B | $ 23.79 | -1.08 % | $ 2.35 B | USA |
 |
Benitec Biopharma
BNTC
|
388 M | $ 8.58 | -0.81 % | $ 399 M | USA |
 |
Capricor Therapeutics
CAPR
|
1.21 B | $ 5.72 | -3.54 % | $ 266 M | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
3.41 B | - | -1.52 % | $ 24.7 M | USA |
 |
Cerus Corporation
CERS
|
632 M | $ 2.37 | 1.5 % | $ 452 M | USA |
 |
Cullinan Management
CGEM
|
850 M | $ 14.55 | 1.25 % | $ 877 M | USA |
 |
Curis
CRIS
|
18.9 M | $ 0.38 | -2.33 % | $ 5 M | USA |
 |
CorMedix
CRMD
|
276 M | $ 7.95 | 1.27 % | $ 573 K | USA |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
10.2 B | $ 14.37 | 3.53 % | $ 929 M | USA |
 |
NuCana plc
NCNA
|
85.3 B | $ 1.03 | 4.54 % | $ 11.6 B | Britain |
 |
BioVie
BIVI
|
-12.6 M | $ 1.33 | 7.26 % | $ 1.96 M | USA |
 |
CEL-SCI Corporation
CVM
|
21.1 M | $ 1.6 | -1.84 % | $ 12.8 M | USA |
 |
PMV Pharmaceuticals
PMVP
|
59.5 M | $ 1.15 | -9.84 % | $ 60.4 M | USA |
 |
Cytokinetics, Incorporated
CYTK
|
1.97 B | $ 60.7 | -0.87 % | $ 7.29 M | USA |